人乳低聚糖对婴幼儿免疫的作用

潘维伟; 李在玲

doi:10.11852/zgetbjzz2019-1062

PDF(528 KB)

中国儿童保健杂志 ›› 2020, Vol. 28 ›› Issue (6) : 660-663. DOI: 10.11852/zgetbjzz2019-1062

综述

人乳低聚糖对婴幼儿免疫的作用

潘维伟, 李在玲

作者信息 +

Effects of human milk oligosaccharides on infant immunity

PAN Wei-wei, LI Zai-ling

Author information +

文章历史 +

摘要

人乳低聚糖是一类复合糖,由单糖通过糖苷键连接而成,其有助于婴幼儿免疫系统的发展。人乳低聚糖的一小部分被吸收至体循环,大部分达到结肠。人乳低聚糖除在肠腔和肠粘膜表面,可在全身多个部位发挥免疫功能。本文综述了在婴幼儿期人乳低聚糖与肠道菌群的相互作用,介导的免疫调节,对病原体和过敏反应的抑制。

Abstract

Human lactooligosaccharides(HMOs) are a kind of complex sugars linked by monosaccharides through glycoside bonds,which contribute to the development of infant immune system.A small part of HMOs is absorbed into the systemic circulation,most of which reach the colon.Except for the surface of intestinal cavity and intestinal mucosa,HMOs can exert immune function in many parts of the body.This article reviews the interaction between HMOs and intestinal flora in infancy,mediation of immunoregulation,and inhibition of pathogen as well as allergic reaction.

导出引用

潘维伟, 李在玲. 人乳低聚糖对婴幼儿免疫的作用[J]. 中国儿童保健杂志. 2020, 28(6): 660-663 https://doi.org/10.11852/zgetbjzz2019-1062

PAN Wei-wei, LI Zai-ling. Effects of human milk oligosaccharides on infant immunity[J]. Chinese Journal of Child Health Care. 2020, 28(6): 660-663 https://doi.org/10.11852/zgetbjzz2019-1062

中图分类号： R174

参考文献

[1] Kunz C,Meyer C,Collado MC,et al.Influence of gestational age,secretor,and lewis blood group status on the oligosaccharide content of human milk[J].J Pediatr Gastroenterol Nutr,2017,64(5):789-798.
[2] Rudloff S,Pohlentz G,Borsch C,et al.Urinary excretion of invivo 13C-labelled milk oligosaccharides in breastfedinfants[J].Br J Nutr,2012,107(7):957-963.
[3] Newburg DS,Ko JS,Leone S,et al.Human milkoligosaccharides and synthetic galactosyloligosaccharides contain 3′-,4-,and 6′-galactosyllactose and attenuate inflammation in human T84,NCM-460,and H4 cells and intestinal tissue ex vivo[J].J Nutr,2016,146(2):358-367.
[4] Laucirica DR,Triantis V,Schoemaker R,et al.Milkoligosaccharides inhibit human rotavirus infectivity in MA104 cells[J].J Nutr,2017,147(9):1709-1714.
[5] Matsuki T,Yahagi K,Mori H,et al.A key genetic factor for fucosyllactose utilization affects infant gut microbiotadevelopment[J].Nat Commun,2016,24(7):11939.
[6] Putignani L,Del Chierico F,Petrucca A,et al.The human gut microbiota:A dynamic interplay with the host from birth to senescence settled during childhood[J].Pediatr Res,2014,76(1):2-10.
[7] Coppa GV,Facinelli B,Magi G,et al.human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and SaImoneUa fyris to human intestinal cells[J].Pediatr Res,2016,79(4):603-607.
[8] Bode L.The functional biology of human milk oligosaccharides[J].Early Hum Dev,2015,91(11):619-622.
[9] Fukuda S,Toh H,Hase K,et al.Bifidobacteria can protect from enteropathogenic infection through production of acetate[J].Nature,2011,469(7331):543-547.
[10] Canfora EE,Jocken JW.Blaak EE.Short-chain fatty acids in control of body weight and insulin sensitivity[J].Nat Rev Endocrinol.2015,11(10):577-591.
[11] Hur KY,Lee MS.Gut Microbiota and metabolic disorders[J].Diabetes Metab,2015,39(3),198-203.
[12] Kim CH.Immune regulation bymicrobiome metabolites[J].Immunology,2018,154(2):220-229.
[13] He Y,Liu S,LeoneS,et al.Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine[J].Mucosal Immunol,2014,7(6):1326-1339.
[14] He Y,Liu S,Kling DE,et al.The human milk oligosaccharide 20-fucosyllactose modulates CD14 expression in human enterocytes,therebyattenuating LPS-induced inflammation[J].Gut,2016,65(1):33-46.
[15] Kuntz S,Rudloff S,Kunz C.Oligosaccharides from human milkinfluence growth-related characteristics of intestinally transformedand non-transformed intestinal cells[J].Br J Nutr,2008,99(3):462-471.
[16] Lane JA,O′Callaghan J,Carrington SD,et al.Transcriptional response of HT-29 intestinalepithelial cells to human and bovine milk oligosaccharides[J].Br J Nutr,2013,110(12):2127-2137.
[17] Li M,Monaco MH,Wang,M,et al.Human milk oligosaccharides shorten rotavirus-induced diarrhea andmodulate piglet mucosal immunity and colonic microbiota[J].ISME J,2014,8(8):1609-1620.
[18] Comstock SS,Li M,Wang M,et al.Dietary human milk oligosaccharides but not prebiotic oligosaccharides increase circulating natural killercell and mesenteric lymph node memory t cell populations in noninfected and rotavirus-infected neonatalpiglets[J].Br J Nutr,2017,147(6):1041-1047.
[19] Newburg DS,Tanritanir AC,ChakIabani S.Lactodifucotetraose a human milk oligosaccharide,attenuates platelet function andinnammatory cytokine release[J].J Thromb Thrombolysis,2016,42(1):46-55.
[20] Bhargava P,Li C,Stanya KJ,et al.Immuno modulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways[J].Nat Med,2012,18(11):1665-1672.
[21] Kulinich A,Liu L.Human milk oligosaccharides:The role in the fine-tuning of innate immune responses[J].Carbohydr Re,2016,432(2):62-70.
[22] Xiao L,Land BV,Engen PA,et al.Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice[J].Sci Rep,2018,8(1):3829.
[23] Newburg DS,Ruiz-Palacios GM,Morrow AL.Human milk glycans protect infants against enteric pathogens[J].Annu Rev Nutr,2005,25:37-58.
[24] Enam F,Mansell TJ.Linkage-Specific Detection and metabolism of human milk oligosaccharides in Escherichia coli[J].Cell Chem Bio,2018,25(10):1292-1303.
[25] Martín-Sosa S,Martín MJ,Hueso P.The sialylated fraction of milk oligosaccharides is partially responsiblefor binding to enterotoxigenic and uropathogenic Escherichia coli human strains[J].J Nutr,2002,132(10):3067-3072.
[26] Manthey CF,Autran,CA,Eckmann L,et al.Human milk oligosaccharides protect againstenteropathogenic Escherichia coli attachment in vitro and EPEC colonization in suckling mice[J].J Pediatr Gastroenterol Nutr,2014,58(2):165-168.
[27] Jantscher-Krenn E,Lauwaet T,Bliss LA,et al.Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro[J].Br J Nutr,2012,108(10):1839-1846.
[28] Morozov V,Hansman G,Hanisch FG,et al.Human milk oligosaccharides as promising antivirals[J].Mol Nutr Food Res,2018,62(6):e1700679.
[29] Weicher S,Koromyslova A,Singh BK,et al.Structural basis for Norovirus inhibition by human milk oligosaccharides[J].J Virol,2016,90(9):4843-4848.
[30] Duska-McEwen G,Senft AP,Ruetschilling TL,et al.Human milk oligosaccharides enhance innate immunity to respiratory syncytial virus and influenza in vitro[J].Food Nutr Sci,2014,5(27):1387-1398.
[31] Seppo AE,Autran CA,Bode L.Human milk oligosacchaddesand development of cow′s milk allergy in infants[J].J Allergy Clin Immunol,2017,139(2):708-711.
[32] Goehring KC,Marriage BJ,Oliver JS,et al..Similar to those who are breastfed,infants fed a formula containing 2′-fucosyllactose have lower inflammatory cytokines in a randomizedcontrolled trial[J].J Nutr,2016,146(12):2559-2566.
[33] Xiao L,Leusink-Muis T,Kettelarij N,et al.Human milk oligosaccharide 2′-fucosyllactose improves innate and adaptive immunity in an influenza-specific murine vaccination model[J].Front Immunolm,2018,9(9):452.
[34] Sprenger N,Odenwald H,Kukkonen AK,et al.FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5years of age in infants with high hereditary allergy risk[J].Eur J Nutr,2017,56(3):1293-1301.
[35] Castillo-Courtade L,Han S,Lee S,et al.Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model[J].Allergy,2015,70(9):1091-1102.